86 related articles for article (PubMed ID: 11952141)
1. Differential processing of HLA A2-restricted HIV type 1 cytotoxic T lymphocyte epitopes.
Sewell AK; Booth BL; Cerundolo V; Phillips RE; Price DA
Viral Immunol; 2002; 15(1):193-6. PubMed ID: 11952141
[TBL] [Abstract][Full Text] [Related]
2. Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.
Cohen WM; Bianco A; Connan F; Camoin L; Dalod M; Lauvau G; Ferriès E; Culmann-Penciolelli B; van Endert PM; Briand JP; Choppin J; Guillet JG
J Virol; 2002 Oct; 76(20):10219-25. PubMed ID: 12239297
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
Sewell AK; Price DA; Teisserenc H; Booth BL; Gileadi U; Flavin FM; Trowsdale J; Phillips RE; Cerundolo V
J Immunol; 1999 Jun; 162(12):7075-9. PubMed ID: 10358150
[TBL] [Abstract][Full Text] [Related]
4. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.
Gavioli R; Vertuani S; Masucci MG
Int J Cancer; 2002 Oct; 101(6):532-8. PubMed ID: 12237893
[TBL] [Abstract][Full Text] [Related]
6. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
[TBL] [Abstract][Full Text] [Related]
7. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
[TBL] [Abstract][Full Text] [Related]
8. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
[TBL] [Abstract][Full Text] [Related]
9. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
10. Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen.
Okazaki T; Pendleton CD; Lemonnier F; Berzofsky JA
J Immunol; 2003 Sep; 171(5):2548-55. PubMed ID: 12928405
[TBL] [Abstract][Full Text] [Related]
11. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of human cytotoxic T cells with HIV-1-derived peptides presented by recombinant HLA-A2 peptide complexes.
Walter JB; Brander C; Mammen M; Garboczi DN; Kalams SA; Whitesides GM; Walker BD; Eisen HN
Int Immunol; 1997 Mar; 9(3):451-9. PubMed ID: 9088983
[TBL] [Abstract][Full Text] [Related]
14. Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications.
Dela Cruz CS; Tan R; Rowland-Jones SL; Barber BH
Int Immunol; 2000 Sep; 12(9):1293-302. PubMed ID: 10967024
[TBL] [Abstract][Full Text] [Related]
15. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.
Yusim K; Kesmir C; Gaschen B; Addo MM; Altfeld M; Brunak S; Chigaev A; Detours V; Korber BT
J Virol; 2002 Sep; 76(17):8757-68. PubMed ID: 12163596
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
[TBL] [Abstract][Full Text] [Related]
18. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
19. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
Hadida F; Haas G; Zimmermann N; Hosmalin A; Spohn R; Samri A; Jung G; Debre P; Autran B
J Immunol; 1995 Apr; 154(8):4174-86. PubMed ID: 7535824
[TBL] [Abstract][Full Text] [Related]
20. Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100 209-217 and gp100 209-217T210M.
Nagorsen D; Servis C; Lévy N; Provenzano M; Dudley ME; Marincola FM; Lévy F
Cancer Immunol Immunother; 2004 Sep; 53(9):817-24. PubMed ID: 15133631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
